Answers are grounded in this paper and cite their sources.
This analysis identifies biomarker signatures predicting survival in colorectal cancer, suggesting new treatment targets.
The findings of the present study provided a set of four key genes with valid clinical utility that can serve as an alternative tool for prognosis and identification of new targets in CRC treatment.
No takes yet. Share an insight, caveat, or question.
Jahantab et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: